Many patients with AIDS in Haiti who received antiretroviral therapy had a one-year survival of 87 percent for adults and 98 percent for children, triple the 30 percent one-year survival of Haitian patients without the therapy, according to a study.
'You are the unsung heroes and heroines of our society,' media star Katie Couric, co-anchor of NBC's 'Today' show, said in a moving speech to doctors and other health-care professionals gathered to discuss crucial updates and issues in gastrointestinal cancers.
A new study using an old, misunderstood technique -- hypnotic suggestion -- finds the brain can override responses experts have long assumed to be ingrained and automatic, such as reading. (Aug. 1, 2005)
Revisiting a hallowed ritual for doctors, a committee within the Weill Cornell Medical College convened this spring to craft an updated Hippocratic Oath, one that responds to the state of modern medicine. Written in ancient Greece, the oath expresses principles still fundamental to the practice of medicine today. (June 22, 2005)
Vaccines that train the immune system to seek out and destroy malignant cells are at the cutting edge of cancer treatment. Now, joint research – conducted by researchers at Weill Medical Cornell and at the Ludwig Institute for Cancer Research Memorial Sloan-Kettering Cancer Center Branch in New York – has pinpointed two proteins that seem ideal targets for a vaccine against multiple myeloma.
For the first time, advanced neurological imaging suggests the brains of minimally conscious patients recognize and respond to speech in ways similar to healthy individuals, according to a team of researchers. (Feb. 7, 2005)
For the first time, scientists have shown how the activity of a gene associated with normal human development, as well as the occurrence of cancer and several other diseases, is repressed epigenetically – by modifying not the DNA code of a gene, but instead the spool-like histone proteins around which DNA tightly wraps itself in the nucleus of cells in the body.
Previous attempts in mice to correct a rare inherited immune disorder, called Hyper IgM X-linked immunodeficiency, have failed because standard gene therapy raised risks for cancer. Now Weill Cornell Medical College researchers believe they've found a way around that problem.
Researchers at NewYork-Presbyterian/Weill Cornell Report Findings of Phase I Clinical Trial of Monoclonal Antibody Treatment for Advanced Prostate Cancer.
